Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2096

1.

WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.

Cuddihy AR, Jalali F, Coackley C, Bristow RG.

Mol Cancer Ther. 2008 Apr;7(4):980-92. doi: 10.1158/1535-7163.MCT-07-0471.

2.

Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation.

Bristow RG, Hu Q, Jang A, Chung S, Peacock J, Benchimol S, Hill R.

Oncogene. 1998 Apr 9;16(14):1789-802.

3.

Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines.

Burger H, Nooter K, Boersma AW, Kortland CJ, van den Berg AP, Stoter G.

Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):415-24.

PMID:
9607360
4.

The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy.

Bristow RG, Benchimol S, Hill RP.

Radiother Oncol. 1996 Sep;40(3):197-223. Review.

PMID:
8940748
5.

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE.

Cell Growth Differ. 1995 Nov;6(11):1395-403.

7.

Resistance to DNA-damaging agents is discordant from experimental metastatic capacity in MEF ras-transformants-expressing gain of function MTp53.

Bristow RG, Peacock J, Jang A, Kim J, Hill RP, Benchimol S.

Oncogene. 2003 May 15;22(19):2960-6.

PMID:
12771947
8.

Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.

DeWeese TL, Walsh JC, Dillehay LE, Kessis TD, Hedrick L, Cho KR, Nelson WG.

Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):145-54.

PMID:
9054890
9.

Human T-cell leukemia virus I tax protein sensitizes p53-mutant cells to DNA damage.

Mihaylova VT, Green AM, Khurgel M, Semmes OJ, Kupfer GM.

Cancer Res. 2008 Jun 15;68(12):4843-52. doi: 10.1158/0008-5472.CAN-07-5070.

10.

Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway.

Li CH, Tzeng SL, Cheng YW, Kang JJ.

J Biol Chem. 2005 Jul 15;280(28):26193-9. Epub 2005 May 19.

11.

Repair of DNA double-strand breaks and radiosensitivity to killing in an isogenic group of p53 mutant cell lines.

DiBiase SJ, Guan J, Curran WJ Jr, Iliakis G.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):743-51.

PMID:
10524431
12.

p53 modulates radiation sensitivity independent of p21 transcriptional activation.

Mazzatti DJ, Lee YJ, Helt CE, O'Reilly MA, Keng PC.

Am J Clin Oncol. 2005 Feb;28(1):43-50.

PMID:
15685034
13.
14.

Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.

Hayward RL, Schornagel QC, Tente R, Macpherson JS, Aird RE, Guichard S, Habtemariam A, Sadler P, Jodrell DI.

Cancer Chemother Pharmacol. 2005 Jun;55(6):577-83. Epub 2005 Feb 22.

PMID:
15726367
15.

p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.

Fan S, el-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW, O'Connor PM.

Cancer Res. 1994 Nov 15;54(22):5824-30.

16.

[Cell cycle regulation after exposure to ionizing radiation].

Teyssier F, Bay JO, Dionet C, Verrelle P.

Bull Cancer. 1999 Apr;86(4):345-57. Review. French.

17.

The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.

Liu XF, Xia YF, Li MZ, Wang HM, He YX, Zheng ML, Yang HL, Huang WL.

Cell Biol Int. 2006 Mar;30(3):283-7. Epub 2006 Jan 30.

PMID:
16448826
18.

Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.

Kelley LL, Hicks GG, Hsieh FF, Prasher JM, Green WF, Miller MD, Eide EJ, Ruley HE.

Oncogene. 1998 Sep 3;17(9):1119-30.

19.

Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.

Nagata Y, Takahashi A, Ohnishi K, Ota I, Ohnishi T, Tojo T, Taniguchi S.

Int J Oncol. 2010 Oct;37(4):1001-10.

PMID:
20811722
20.

p53-Dependent activation of a molecular beacon in tumor cells following exposure to doxorubicin chemotherapy.

Shah R, El-Deiry WS.

Cancer Biol Ther. 2004 Sep;3(9):871-5. Epub 2004 Sep 21.

PMID:
15254427

Supplemental Content

Support Center